BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4277102)

  • 1. The use of 5-HTP in the treatment of Down's syndrome.
    Weise P; Koch R; Shaw KN; Rosenfeld MJ
    Pediatrics; 1974 Aug; 54(2):165-8. PubMed ID: 4277102
    [No Abstract]   [Full Text] [Related]  

  • 2. Fate of 14C-labelled tryptophan and 5-hydroxytryptophan in Down's syndrome.
    Airaksinen EM; Airaksinen MM; Pentikäinen P
    Ann Clin Res; 1973 Dec; 5(6):385-91. PubMed ID: 4275982
    [No Abstract]   [Full Text] [Related]  

  • 3. 5-hydroxytryptophan (5-HTP) in Down's syndrome.
    Partington MW; MacDonald MR
    Dev Med Child Neurol; 1971 Jun; 13(3):362-72. PubMed ID: 4255254
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapy with 5-hydroxytryptophan of Down's disease].
    Simonsson H
    Nord Med; 1969 Jul; 81(31):952-4. PubMed ID: 4241288
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of probenecid on 5-hydroxyindoles in cerebrospinal fluid in Down's syndrome.
    Airaksinen EM; Kauko K
    Ann Clin Res; 1973 Dec; 5(6):392-4. PubMed ID: 4275983
    [No Abstract]   [Full Text] [Related]  

  • 6. [Urinary excretion of 5-hydroxyindoleacetic acid. II. In children with phenylketonuria, effects of 5-hydroxytryptophan].
    Costil J; Galli J; Richardet JM; Brissaud HE
    Nouv Presse Med; 1973 Sep; 2(32):2118-22. PubMed ID: 4542594
    [No Abstract]   [Full Text] [Related]  

  • 7. Tryptophan treatment of infants with Down's syndrome.
    Airaksinen EM
    Ann Clin Res; 1974 Feb; 6(1):33-9. PubMed ID: 4274411
    [No Abstract]   [Full Text] [Related]  

  • 8. Sleep EEG patterns in a case of Down's syndrome--before and after 5-HTP.
    Lee JC; Ornitz EM; Tanguay PE; Ritvo ER
    Electroencephalogr Clin Neurophysiol; 1969 Sep; 27(7):686. PubMed ID: 4187354
    [No Abstract]   [Full Text] [Related]  

  • 9. [Down's syndrome and serotonin].
    Oura T; Uemura I
    Saishin Igaku; 1968 Feb; 24(2):328-31. PubMed ID: 4239279
    [No Abstract]   [Full Text] [Related]  

  • 10. 5-Hydroxytryptophan and sleep in Down's syndrome.
    Petre-Quadens O; De Lee C
    J Neurol Sci; 1975 Nov; 26(3):443-53. PubMed ID: 171348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letter: Self mutilation in Lesch-Nyhan syndrome.
    Mizuno TI; Yugari Y
    Lancet; 1974 Apr; 1(7860):761. PubMed ID: 4132504
    [No Abstract]   [Full Text] [Related]  

  • 12. Mental and developmental milestones of noninstitutionalized Down's syndrome children.
    Melyn MA; White DT
    Pediatrics; 1973 Oct; 52(4):542-5. PubMed ID: 4270249
    [No Abstract]   [Full Text] [Related]  

  • 13. Medicinal treatment for relief of hypotonia in Down's Syndrome.
    Griffiths MI
    Physiotherapy; 1976 Jan; 62(1):19-20. PubMed ID: 130644
    [No Abstract]   [Full Text] [Related]  

  • 14. Neurologic aspects of typical and atypical Down's syndrome.
    Paulson GW; Son CD; Nance WE
    Dis Nerv Syst; 1969 Sep; 30(9):632-6. PubMed ID: 4242004
    [No Abstract]   [Full Text] [Related]  

  • 15. [Studies on the L-tryptophan metabolism in children with Down's syndrome].
    Vassella F; Colombo JP; Gloor RD; Rossi E
    Helv Paediatr Acta; 1968 Aug; 23(4):419-28. PubMed ID: 4234242
    [No Abstract]   [Full Text] [Related]  

  • 16. [Excretion of 5-hydroxyindoleacetic acid in the urine of sarcoma-45 bearing rats after administration of serotonin, 5-hydroxytryptophan and tryptophan].
    Mal'tseva LF; Brazhnikova ID; Rudzit EA
    Vopr Med Khim; 1968; 14(2):150-2. PubMed ID: 5303056
    [No Abstract]   [Full Text] [Related]  

  • 17. Psychological and social development in home-reared children with Down's syndrome (mongolism).
    Cornwell AC; Birch HG
    Am J Ment Defic; 1969 Nov; 74(3):341-50. PubMed ID: 4243399
    [No Abstract]   [Full Text] [Related]  

  • 18. [The physically and mentally handicapped child I. Down's syndrome. Rehabilitational possibilities].
    Giza T; Slebodzińska A; Klimkowa E; Chodorowska T; Pietrzyk J
    Folia Med Cracov; 1975; 17(4):437-41. PubMed ID: 131057
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of high doses of 5-hydroxytryptophan on a patient with trisomy 21. Clinical, chemical and EEG correlations.
    Bazelon M; Barnet A; Lodge A; Shelburne SA
    Brain Res; 1968 Nov; 11(2):397-411. PubMed ID: 4302675
    [No Abstract]   [Full Text] [Related]  

  • 20. Serotonin levels and intelligence in trisomy-21 type Down's syndrome.
    Marsh RW
    N Z Med J; 1969 Sep; 70(448):179. PubMed ID: 4242285
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.